Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1472 of 6351
-
New gel could ease pain and heal wounds for kids with butterfly skin
Symptom relief Recruiting nowThis is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel in patients with confirmed DEB or JEB. The study will implement intrasubject randomization, ie, a pair of matching index w…
Phase 2 • Sponsor: Xinnate AB • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can emotional patterns reveal the true nature of teen trauma?
Knowledge-focused Recruiting nowThis study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD). As emotional dysreg…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Bedside test may end guesswork in nerve pain treatment
Knowledge-focused Recruiting nowThe goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain treatments in participants with painful peripheral neuropathy. The analgesic eff…
Phase 2 • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New study tests ozanimod against standard drug for Steroid-Dependent UC
Disease control Recruiting nowThe purpose of this study is to evaluate the effectiveness and safety of ozanimod vs azathioprine for the treatment of ulcerative colitis (UC) in real-world clinical practice in Japan
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Experimental cell therapy takes on lupus and muscle disease
Disease control Recruiting nowThis is a prospective, single-arm, open-label and dose-escalation investigator initialed study to evaluate LUCAR-G79D in adult subjects with r/r SLE and r/r IIM.
Phase 1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a diabetes drug help fight opioid addiction?
Disease control Recruiting nowThe primary objective of this research study is to evaluate the effect of tirzepatide, relative to placebo, as an adjunct to BUP on retention, substance use, and sleep outcomes in individuals with OUD.
Phase 2 • Sponsor: T. John Winhusen, PhD • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New study tracks Darolutamide's Real-World impact on advanced prostate cancer
Disease control OngoingThis is an international, prospective, open-label, multicenter, multi-cohort, non-interventional observational study designed to describe the real-world effectiveness and safety of darolutamide in combination with androgen deprivation therapy (ADT), with or without docetaxel, in …
Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Probiotic drink offers hope for coeliac sufferers with persistent gut pain
Symptom relief Recruiting nowCoeliac Disease (CD) is a lifelong autoimmune condition where eating gluten (a protein found in wheat, barley, and rye) causes damage to the small intestine. It affects around 1 in 100 people. Most individuals feel better and their gut heals after switching to a strict gluten-fre…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can knee cartilage reveal why osteoarthritis worsens?
Knowledge-focused By invitation onlyBefore you are included in this study, you will undergo the following examinations to determine if you are eligible to participate: Before you are included in this study, your doctor will ask and record your medical history, conduct a physical examination on you, and perform nece…
Sponsor: Yunnan University of Chinese Medicine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New hope for IBD patients: switching to guselkumab after ustekinumab fails
Disease control Recruiting nowThe SHIFT-IBD Study is being conducted at multiple medical centers across Canada to evaluate how well guselkumab (Tremfya) works for people with inflammatory bowel disease (IBD) who haven't responded well enough to ustekinumab. Patients will begin guselkumab based on their docto…
Sponsor: TIDHI Innovation Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for stomach cancer: targeted drug HS-20093 enters human trials
Disease control Recruiting nowHS-20093 is a humanized IgG1 antibody-drug conjugate (ADC) which specifically binds to B7-H3, a target wildly expressed on solid tumor cells. This is a phase 1b, open-label, multi-center study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of HS-20093 in pa…
Phase 1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Sound waves vs. tumors: new registry tracks Non-Surgical breakthrough
Disease control Recruiting nowHistotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a wearable device keep heart failure patients out of the hospital?
Disease control Recruiting nowThis clinical trial aims to determine whether a ReDS-guided treatment strategy is superior to the current standard of care for adults hospitalized with heart failure. Additionally, the study will evaluate the safety and cost-effectiveness of this approach. The study seeks to ans…
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New pill could tame eye inflammation without needles
Disease control Recruiting nowThe purpose of this study is to find out the efficacy and safety of oral FXS5626 in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Phase 2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug APAC aims to prevent blood clots in leg artery patients
Disease control Recruiting nowThe goal of this study is to learn if a new medicine (called antiplatelet and anticoagulant \[APAC\]) can help the body to prevent blood clots and whether APAC is safe and well tolerated in patients with blocked or narrowed arteries in their legs (peripheral arterial occlusive di…
Phase 2 • Sponsor: Aplagon Oy • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
AI listens for warning signs of psychosis relapse
Knowledge-focused Recruiting nowThis observational, multinational study assesses the feasibility of speech and self-report data collection across six languages for Artificial Intelligence (AI)-driven relapse risk estimation in psychosis. Over 12 months, patients at risk of relapse and healthy controls will prov…
Sponsor: Philipp Homan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New MRI technique aims to spare saliva glands during cancer radiation
Symptom relief Recruiting nowRadiation-induced xerostomia (dry mouth) is one of the most common and severe side effects for patients receiving radiation therapy for head and neck cancer. New approaches are needed to reduce this side effect and improve patients' quality of life after treatment. This is a Pha…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New breast cancer surgery could spare women from unnecessary lymph node removal
Disease control Recruiting nowThe present study aims to avoid axillary lymph node dissection (ALND) in patients with an Ultrasound (US) detected positive preoperative lymph node involvement (1 or 2 suspicious lymph-nodes) and a needle histology/cytology placing a marker in the most suspicious node undergoing …
Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New mesh stent aims to seal brain aneurysms without surgery
Disease control Recruiting nowThe purpose of this study is to assess how safe choydar flow-directed mesh stent is and how well it works in the treatment of unruptured intracranial aneurysms (a condition in which a bulging blood vessel in the brain can burst and cause bleeding) in a real-world setting.
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Recruiting nowA Phase 1/2, open-label, non-randomized, dose-escalation study, where a minimum of 9 and a maximum of 18 eligible patients with Stargardt Disease will be enrolled sequentially in up to 3 dose cohorts of RTx-021. Enrolled patients will receive a single, unilateral intravitreal inj…
Phase 1/2 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC